LATEST NEWS
South Korean FDA Approval For Green Cross’ Neulapeg®
Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.
Picking Up Single Cells Accurately & Cheaply
By modifying the ubiquitous benchtop pipette, researchers have developed a cheap way to isolate single cells.
Obese Men Face Wage Discrimination In China
Obese males in China earn less than their lean counterparts, survey shows.
The Physics Of Wound Healing
Experimental and computational evidence points to a third mechanism of wound healing previously unknown to science.
Sniffing Out An Artificial Insect ‘Nose’
Insect odorant receptors on tiny balls of cells have been used to develop biosensors for gaseous compounds.
Will Indonesia’s Cash For Health Program Work?
Margaret Triyana asks whether Indonesia's proposed health program will translate into long term improvements.
Amerigen’s Mecobalamin Receives CFDA Approval
The CFDA approval of Mecobalamin marks Amerigen's entry into the Chinese generics market.
How Neurons Fire During Absence Seizures
A study in mice questions the role of burst firing neurons in absence seizures and could lead to the development of new modes of treatment.
Teaching Old Drugs New Tricks
Understanding why RUNX deficiencies result in leukemia has led to new applications for PARP inhibitors.












